Novo A/S

Novo Holdings A/S as of June 30, 2017

Portfolio Holdings for Novo Holdings A/S

Novo Holdings A/S holds 21 positions in its portfolio as reported in the June 2017 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Inogen (INGN) 40.5 $339M 3.5M 95.42
Anaptysbio Inc Common (ANAB) 8.7 $73M 3.0M 23.93
Acceleron Pharma 5.7 $47M 1.6M 30.39
Spectranetics Corporation 5.5 $46M 1.2M 38.40
Dermira 5.3 $45M 1.5M 29.14
Corvus Pharmaceuticals (CRVS) 4.7 $39M 3.2M 12.10
Ra Pharmaceuticals 4.6 $38M 2.0M 18.74
Flexion Therapeutics 3.6 $30M 1.5M 20.22
Akebia Therapeutics (AKBA) 3.1 $26M 1.8M 14.37
Nabriva Therapeutics 2.9 $24M 2.3M 10.48
Obseva Sa 2.8 $23M 2.7M 8.55
Merus N V (MRUS) 2.7 $22M 1.4M 15.85
Kalvista Pharmaceuticals (KALV) 2.6 $21M 2.9M 7.36
Reata Pharmaceuticals Inc Cl A 2.2 $19M 593k 31.64
Apollo Endosurgery 1.3 $11M 1.4M 7.89
Invuity 1.2 $9.9M 1.4M 7.25
Verona Pharma Plc ads (VRNA) 1.0 $8.6M 741k 11.66
Wright Medical Group Rtsn V 0.8 $6.7M 4.6M 1.46
Crispr Therapeutics (CRSP) 0.4 $3.6M 223k 16.02
Htg Molecular Diagnostics 0.4 $3.3M 1.2M 2.66
Xenon Pharmaceuticals (XENE) 0.1 $402k 128k 3.15